Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Strongbridge Biopharma plc, Medical Devices Deals, 2012 to YTD 2018 10
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Strongbridge Biopharma Acquires US rights to Keveyis from Taro Pharma 13
Strongbridge Biopharma Acquires Somatoprim from Aspireo Pharma 15
Licensing Agreements 16
Strongbridge Biopharma Enters into Licensing Agreement with Aeterna Zentaris 16
Cortendo Enters into Licensing Agreement with Antisense Therapeutics 17
Equity Offering 19
Strongbridge Biopharma Announces Partial Exercise of Underwriters Option of Public Offering of Shares for USD35.5 Million 19
Strongbridge Biopharma Raises USD25 Million in Public Offering of Shares 21
Strongbridge Biopharma Raises USD3 Million in Private Placement of Shares 23
Strongbridge Biopharma to Raise USD40 Million in Public Offering of Shares 25
Strongbridge Biopharma Plans to Raise Funds through Private Placement of Shares 26
Strongbridge Biopharma Raises USD35 Million in Private Placement of Shares and Warrants 27
Strongbridge Biopharma Raises USD25 Million in IPO 29
Cortendo Raises USD33.2 Million in Private Placement of Shares 31
Cortendo to Raise USD33.2 Million in Private Placement of Shares 32
Strongbridge Biopharma Raises USD26.4 Million in Private Placement of Shares 34
Cortendo Raises USD37.5 Million in Private Placement of Shares 35
Cortendo Raises USD11 Million in Private Placement of Shares 37
Cortendo Raises USD12.6 Million in Private Placement of Shares 38
Cortendo Raises USD2.1 Million in Private Placement of Shares 39
Cortendo Raises USD0.7 Million in Private Placement of Shares 40
Cortendo Raises USD3.1 Million in Private Placement of Shares 41
Strongbridge Biopharma plc – Key Competitors 42
Strongbridge Biopharma plc – Key Employees 43
Strongbridge Biopharma plc – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 45
Financial Announcements 45
Aug 08, 2018: Strongbridge Biopharma reports second quarter 2018 financial results and provides corporate update 45
May 10, 2018: Strongbridge Biopharma Reports First Quarter 2018 Financial Results and Provides Corporate Update 47
Mar 12, 2018: Strongbridge Biopharma Announces Full-Year 2017 Financial Results 49
Nov 14, 2017: Strongbridge Biopharma Provides Corporate Update and Reports Third Quarter 2017 Financial Results 51
Aug 07, 2017: Strongbridge Biopharma Provides Updates on KEVEYIS Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial Results 54
May 16, 2017: Strongbridge Biopharma Provides Corporate Update and Reports First Quarter 2017 Financial Results 57
Mar 27, 2017: Strongbridge Biopharma Provides Corporate Update and Reports Full-Year 2016 Financial Results 59
Clinical Trials 61
Apr 02, 2018: Strongbridge Biopharma Announces Dosing of First Four Patients in LOGICS, a Second Global Phase 3 Study of RECORLEV (levoketoconazole) in Endogenous Cushing’s Syndrome 61
Mar 18, 2018: Strongbridge Biopharma Announces Presentation of New Data Demonstrating That Levoketoconazole is a Potent Inhibitor of Human Enzymes Controlling Cortisol Synthesis 62
Jun 27, 2017: Strongbridge Biopharma Completes Target Enrollment of 90 Patients in the Phase 3 SONICS Study Evaluating RECORLEV (levoketoconazole) in Endogenous Cushing’s Syndrome 63
Other Significant Developments 64
Sep 25, 2017: Strongbridge Biopharma Launches the Uncovering Periodic Paralysis Genetic Testing Program 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Strongbridge Biopharma plc, Deals By Therapy Area, 2012 to YTD 2018 9
Strongbridge Biopharma plc, Medical Devices Deals, 2012 to YTD 2018 10
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Strongbridge Biopharma Acquires US rights to Keveyis from Taro Pharma 13
Strongbridge Biopharma Acquires Somatoprim from Aspireo Pharma 15
Strongbridge Biopharma Enters into Licensing Agreement with Aeterna Zentaris 16
Cortendo Enters into Licensing Agreement with Antisense Therapeutics 17
Strongbridge Biopharma Announces Partial Exercise of Underwriters Option of Public Offering of Shares for USD35.5 Million 19
Strongbridge Biopharma Raises USD25 Million in Public Offering of Shares 21
Strongbridge Biopharma Raises USD3 Million in Private Placement of Shares 23
Strongbridge Biopharma to Raise USD40 Million in Public Offering of Shares 25
Strongbridge Biopharma Plans to Raise Funds through Private Placement of Shares 26
Strongbridge Biopharma Raises USD35 Million in Private Placement of Shares and Warrants 27
Strongbridge Biopharma Raises USD25 Million in IPO 29
Cortendo Raises USD33.2 Million in Private Placement of Shares 31
Cortendo to Raise USD33.2 Million in Private Placement of Shares 32
Strongbridge Biopharma Raises USD26.4 Million in Private Placement of Shares 34
Cortendo Raises USD37.5 Million in Private Placement of Shares 35
Cortendo Raises USD11 Million in Private Placement of Shares 37
Cortendo Raises USD12.6 Million in Private Placement of Shares 38
Cortendo Raises USD2.1 Million in Private Placement of Shares 39
Cortendo Raises USD0.7 Million in Private Placement of Shares 40
Cortendo Raises USD3.1 Million in Private Placement of Shares 41
Strongbridge Biopharma plc, Key Competitors 42
Strongbridge Biopharma plc, Key Employees 43
Strongbridge Biopharma plc, Subsidiaries 44
List of Figures
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Strongbridge Biopharma plc, Medical Devices Deals, 2012 to YTD 2018 10